A toddler in North Dakota will soon undergo major surgery to correct a serious heart defect her mother believes was caused by Zofran. According to a report from ValleyNewsLive.com, the little girl’s mother was prescribed the medication during her pregnancy to help alleviate nausea and vomiting.
“They told me to take it as needed, whenever I felt nauseous but it was the whole time I felt nauseous. I just continued to take it. I thought it was safe,” the child’s mother said in an interview.
The report points out that Zofran is not approved to treat pregnancy-related nausea and vomiting, and that the drug has never been tested on pregnant women. Yet Zofran has long been prescribed off-label to help women experiencing this common pregnancy complication.
The child profiled by the ValleyNewsLife.com report was born with a heart twice the normal size, and with two holes inside. However, the problem was only recently discovered ago via an x-ray, when she was being treated for what appeared to be a routine fever. Yet this little girl is considered lucky, as these types of heart abnormalities aren’t always diagnosed until a patient reaches adulthood and experiences catastrophic cardiovascular problems, such as a stroke.
The 2-year-old’s open heart surgery will keep her and her family away from home for at least a month. Their community is coming together for a benefit on April 18th to raise funds to help offset the cost of her care.
The North Dakota family is apparently not alone in coping with alleged Zofran heart defects. Recently, two federal lawsuits were filed on behalf of children who were born with serious cardiovascular abnormalities, allegedly due to their mothers’ use of Zofran during their first trimester of pregnancy. Among other things, these families accuse GlaxoSmithKline of concealing data that suggested the drug could harm a developing fetus. The Zofran lawsuits also claim that the company illegally promoted the medication as a treatment for morning sickness, even though it was never approved for this purpose.
Just last summer, an article published in The Toronto Star reported that some 20 Canadian women had given birth to children with a variety of congenital abnormalities after they were treated with Zofran or a generic equivalent during their pregnancies. The birth defects detailed in the report included heart malformations, kidney defects, cleft lip and palate, and musculoskeletal problems. The report also discussed a growing body of research that suggests pre-natal exposure to Zofran might harm an unborn baby.
Our attorneys recently launched a Zofran birth defect investigation in response to the growing number of reports linking this anti-nausea medication to congenital heart abnormalities and other problems. If you believe this drug harmed your child, please contact our office to learn more about filing a Zofran Lawsuit. Free case evaluations can be arranged by calling .